Clinical Trial Update: Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity [Phase 3]

View source ↗

Summary

A Phase III trial evaluating Botulax for post-stroke upper limb spasticity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Stroke

Drugs mentioned

• Botulax (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Stroke, Spasticity | Phase 3 | Status: COMPLETED